24/7 Market News Snapshot 23 June, 2025 – Eyenovia, Inc. Common Stock (NASDAQ:EYEN)

June 23, 2025

DENVER, Colo., 23 June, 2025 (www.247marketnews.com) – (NASDAQ:EYEN) are discussed in this article.
Eyenovia, Inc. (NASDAQ:EYEN) has made significant strides in both its market performance and strategic direction. Recently, the company’s stock price soared by nearly 25%, climbing from a previous close of $4.210 to a peak of $5.261 during trading. This surge, accompanied by a robust trading volume of 1.42 million shares, reflects the increasing investor confidence in Eyenovia’s innovative therapeutics aimed at enhancing ocular health.

In a pivotal development, Eyenovia has successfully closed a $50 million private placement with accredited investors, allowing it to procure 1,040,584.5 HYPE tokens, the native currency of the Hyperliquid protocol, at an average price of approximately $34 per token. This acquisition positions Eyenovia as the inaugural publicly-listed company to operate a validator on the Hyperliquid blockchain. Michael Rowe, CEO of Eyenovia, remarked on this financing initiative, emphasizing that it is a strategic move intended to generate long-term shareholder value.

Additionally, Eyenovia’s flagship Optejet User Filled Device (UFD) is on track for FDA registration by September 2025, representing a significant advancement in the treatment of chronic front-of-the-eye diseases. The UFD’s user-centric design aims to enhance patient compliance and is being positioned for potential partnerships in applications such as over-the-counter lens rewetting and artificial tears.

As part of its commitment to align with the expanding digital finance landscape, Eyenovia plans to undergo a rebranding, transitioning to the name “Hyperion DeFi” (HYPD). This reflects the company’s dedication to integrating its groundbreaking advances in ophthalmic technology with the burgeoning blockchain ecosystem, aiming to deliver secure and innovative investment opportunities for both retail and institutional stakeholders. Eyenovia’s aggressive strategy underscores its ambition to lead in the intersection of health and digital finance.

Related news for (EYEN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.